Industry cautious over Philippine FDA's planned fee hike
This article was originally published in Scrip
Executive Summary
The Philippine FDA has held its first hearings with industry over proposed big increases to the fees it charges for its services. The changes are part of efforts to improve the finances of the regulatory body, to allow it to expand its operations and perform more effectively.